Login
Boehringer Ingelheim
  • Therapeutic Area
    • Resources
    • Contact
    Login

    YOUR FORESIGHT. HIS FUTURE.
    The first NOAC with
    a reversal agent

    YOUR FORESIGHT.
    HIS FUTURE.

    Dabigatran etexilate (Pradaxa®) is proven to be safe and effective to lower the risk of stroke and gives you the assurance of reversibility with Idarucizumab (Praxbind®) in emergency situations.1,2

    1. Connolly et al. N Engl J Med 2009
    2. Praxbind SMPC

    pradaxa-logo pradaxa-logo pradaxa-logo

    1. Connolly et al. N Engl J Med 2009
    2. Praxbind SMPC

    Close ×
    • Resources
      • Site map
      • Terms of use
      • Privacy
      • Contact

      © 2010-2025
      Boehringer Ingelheim International GmbH.
      All rights reserved.